Akin Melih, Erginel Basak, Karadag Cetin Ali, Yildiz Abdullah, Ozçelik Gül Sumru, Sever Nihat, Genc Nimetullah Mete, Dokucu Ali Ihsan
Pediatric Surgery Department, Sisli Etfal Education and Training Hospital, Istanbul, Turkey.
Int Urol Nephrol. 2014 Nov;46(11):2057-61. doi: 10.1007/s11255-014-0771-5. Epub 2014 Jun 26.
We aimed to compare the success rates of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the treatment of primary vesicoureteral reflux (VUR) with a new nonbiodegradable tissue-augmenting substance (Vantris, Promedon, Cordoba, Argentina).
Between January 2011 and December 2012, fifty-two children who underwent subureteric injection for primary VUR are included. The children were randomly separated into two groups, the HIT and the double HIT groups, according to the type of injection. Success was defined as no reflux on a follow-up voiding cystourethrogram (VCUG) after 6 months. The patients were evaluated according to sex, age, grade of reflux, number of injections, and injected volume, and the radiological success rates were compared.
Fifty-two patients underwent an endoscopic injection for primary grade III-V VUR. The HIT group consisted of 26 patients with 33 ureters, and the double HIT group consisted of 26 patients with 35 ureters. There were no significant differences in terms of the sex, ages, VUR grades, bilaterality between the two groups. The mean injected volumes were ml 1.12 (1.02-1.22) in the HIT group and 1.24 ml (95 % CI 1.10-1.38) in the double HIT group. The reflux was resolved in 21/33 (63.6 %) ureters in the HIT group and in 30/35 (85.7 %) ureters in the double HIT group, (p < 0.05). We had only one complication. This patient in the double HIT group, developed bilateral hydronephrosis and oliguric renal failure requiring open reimplantation at the sixth month.
We observed successful results double HIT method with PPC in Grade III-V reflux, but the long-term follow-up of patients is needed for hydronephrosis. As the double HIT treatment leads to a higher success rate, its use is preferable.
我们旨在比较双水扩张植入技术(HIT)和使用聚丙烯酸酯/多元醇共聚物(PPC)的HIT治疗原发性膀胱输尿管反流(VUR)的成功率,该治疗采用一种新型不可生物降解的组织增强物质(Vantris,Promedon,科尔多瓦,阿根廷)。
纳入2011年1月至2012年12月间因原发性VUR接受输尿管下注射的52名儿童。根据注射类型,将儿童随机分为两组,即HIT组和双HIT组。成功定义为6个月后随访排尿性膀胱尿道造影(VCUG)时无反流。根据性别、年龄、反流程度、注射次数和注射量对患者进行评估,并比较放射学成功率。
52例患者接受了内镜下原发性III - V级VUR注射治疗。HIT组由26例患者共33条输尿管组成,双HIT组由26例患者共35条输尿管组成。两组在性别、年龄、VUR程度、双侧性方面无显著差异。HIT组平均注射量为1.12 ml(1.02 - 1.22),双HIT组为1.24 ml(95%可信区间1.10 - 1.38)。HIT组33条输尿管中有21条(63.6%)反流消失,双HIT组35条输尿管中有30条(85.7%)反流消失,(p < 0.05)。我们仅出现1例并发症。双HIT组的这名患者在第6个月出现双侧肾积水和少尿性肾衰竭,需要进行开放再植术。
我们观察到双HIT联合PPC方法在III - V级反流中取得了成功结果,但肾积水患者需要长期随访。由于双HIT治疗成功率更高,因此更宜采用。